跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Mediaven Forte - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Mediaven Forte
Approved
STANDARD
Mediaven Forte
Haupt Pharma Berlin GmbH
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
67b4487c0a64ed11
Company
Haupt Pharma Berlin GmbH
Type
Standard
Approval Details
Approval Id
67b4487c0a64ed11
Drug Approval Philippines Name
Mediaven Forte
Product Name
Mediaven Forte
Registration Number
DR-XY41262
Brand Name
Mediaven Forte
Generic Name
Naftazone
Dosage Form
Film-Coated Tablet
Dosage Strength
30 mg
Manufacturer
Haupt Pharma Berlin GmbH
Trader
Drossapharm AG
Importer
Multicare Pharmaceuticals Phils., Inc.
Distributor
Multicare Pharmaceuticals Phils., Inc.
Trader Detail Path
/organization/drossapharm-ag
Issuance Date
27 May 2022
Expiry Date
01 October 2025
Pharmacologic Category
Vasoprotective (Capillary Stabilizing Agent)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
67b4487c0a64ed11
Type
Standard
Back to Philippines FDA Approvals